[PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
D000324:Adrenocorticotropic Hormone; D000450:Aldosterone; D001201:Ascites; D001826:Body Fluids; D002965:Classification; D003907:Dexamethasone; D005110:Extracellular Space; D006929:Hyperaldosteronism; D006973:Hypertension; D006974:Hypertension, Malignant; D007684:Kidney Tubules; D008103:Liver Cirrhosis; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D009318:Natriuresis; D009404:Nephrotic Syndrome; D010336:Pathology; D010600:Pharmacology; D010827:Physiology; D011188:Potassium; D012964:Sodium; D013148:Spironolactone; D014116:Toxicology; D014308:Triparanol
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000450:Aldosterone; D014308:Triparanol; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D012964:Sodium; D011188:Potassium; D008797:Metyrapone
ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ASCITES; BODY FLUIDS; CLASSIFICATION; CORTICOTROPIN; DEXAMETHASONE; EXTRACELLULAR SPACE; HYPERALDOSTERONISM; HYPERTENSION, MALIGNANT; KIDNEY TUBULES; LIVER CIRRHOSIS; METYRAPONE; NATRIURESIS; NEPHROTIC SYNDROME; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; POTASSIUM; SODIUM; SPIRONOLACTONE; TOXICOLOGIC REPORT; TRIPARANOL
PATOFISIOLOG'IA Y CL'INICA DEL ALDOSTERONISMO SECUNDARIO Y SU TRATAMIENTO.